Epigenetics in idiopathic pulmonary fibrosis1

Biochemistry and Cell Biology

Volumn 93, Issue 2, 2015, Pages 159-170

  Tzouvelekis, Argyrios ^a   Kaminski, Naftali ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA methylation; Epigenetic treatments; Fibroproliferative disorders; Histone modification; Noncoding RNAs

Indexed keywords

ALKYLATION; DIAGNOSIS; DISEASES; GENES; NUCLEIC ACIDS; REPAIR;

DNA METHYLATION; EPIGENETIC TREATMENTS; FIBROPROLIFERATIVE DISORDERS; HISTONE MODIFICATION; NON-CODING RNAS;

BIOLOGICAL ORGANS;

LONG UNTRANSLATED RNA; UNTRANSLATED RNA;

ANIMAL; ASTHMA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA METHYLATION; EPIGENETICS; FIBROSING ALVEOLITIS; FIBROSIS; GENETIC EPIGENESIS; GENETIC REGULATION; GENETICS; HEART MUSCLE FIBROSIS; HISTONE MODIFICATION; HUMAN; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG CANCER; LUNG DISEASE; MOUSE; NONHUMAN; PATHOLOGY; REVIEW;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROSIS; GENETICS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES; MICE; PATHOLOGY; RNA, LONG NONCODING;

EID: 84964292862     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0126     Document Type: Review

References (119)

1. Andresen E. Gunther G. Bullwinkel J. Lange C. Heine H. 2011. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One, 6 (7): e21898. 10.1371/journal.pone.0021898. 21818276.
2. Antoniou K.M. Hansell D.M. Rubens M.B. Marten K. Desai S.R. Siafakas N.M. et al 2008. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am. J. Respir. Crit. Care Med. 177 (2): 190-194. 10.1164/rccm.200612-1759OC. 17962635.
3. Bechtel W. McGoohan S. Zeisberg E.M. Muller G.A. Kalbacher H. Salant D.J. et al 2010. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16 (5): 544-550. 10.1038/nm.2135. 20418885.
4. Bianchi F. Nicassio F. Marzi M. Belloni E. Dall'olio V. Bernard L. et al 2011. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 3 (8): 495-503. 10.1002/emmm.201100154. 21744498.
5. Blackwell T.S. Tager A.M. Borok Z. Moore B.B. Schwartz D.A. Anstrom K.J. et al 2013. Future Directions in Idiopathic Pulmonary Fibrosis Research: An NHLBI Workshop Report. Am. J. Respir. Crit. Care Med. 10.1164/rccm.201306-1141WS. 24160862.
6. Bogaard H.J. Mizuno S. Hussaini A.A. Toldo S. Abbate A. Kraskauskas D. et al 2011. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am. J. Respir. Crit. Care Med. 183 (10): 1402-1410. 10.1164/rccm.201007-1106OC. 21297075.
7. Bonasio R. Tu S. Reinberg D. 2010. Molecular signals of epigenetic states. Science, 330 (6004): 612-616. 10.1126/science.1191078. 21030644.
8. Breton C.V. Byun H.M. Wenten M. Pan F. Yang A. Gilliland F.D. 2009. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med. 180 (5): 462-467. 10.1164/rccm.200901-0135OC. 19498054.
9. Cabrera S. Selman M. Lonzano-Bolanos A. Konishi K. Richards T.J. Kaminski N. Pardo A. 2013. Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 304 (9): L593-L601. 10.1152/ajplung.00320.2012. 23457188.
10. Cano C.E. Gommeaux J. Pietri S. Culcasi M. Garcia S. Seux M. et al 2009. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res. 69 (1): 219-226. 10.1158/0008-5472.CAN-08-2320. 19118006.
11. Cao G. Zhang J. Wang M. Song X. Liu W. Mao C. Lv C. 2013. Differential expression of long non-coding RNAs in bleomycin-induced lung fibrosis. Int. J. Mol. Med. 32 (2): 355-364. 10.3892/ijmm.2013.1404. 23732278.
12. Cisneros J. Hagood J. Checa M. Ortiz-Quintero B. Negreros M. Herrera I. et al 2012. Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 303 (4): L295-L303. 10.1152/ajplung.00332.2011. 22707614.
13. Coward W.R. Watts K. Feghali-Bostwick C.A. Knox A. Pang L. 2009. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol. Cell. Biol. 29 (15): 4325-4339. 10.1128/MCB.01776-08. 19487460.
14. Coward W.R. Watts K. Feghali-Bostwick C.A. Jenkins G. Pang L. 2010. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol. Cell. Biol. 30 (12): 2874-2886. 10.1128/MCB.01527-09. 20404089.
15. Crowley E. Di Nicolantonio F. Loupakis F. Bardelli A. 2013. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10 (8): 472-484. 10.1038/nrclinonc.2013.110. 23836314.
16. Cuddapah S. Barski A. Zhao K. 2010. Epigenomics of T cell activation, differentiation, and memory. Curr. Opin. Immunol. 22 (3): 341-347. 10.1016/j.coi.2010.02.007. 20226645.
17. Cushing L. Kuang P.P. Qian J. Shao F. Wu J. Little F. et al 2011. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45 (2): 287-294. 10.1165/rcmb.2010-0323OC. 20971881.
18. Dakhlallah D. Batte K. Wang Y. Cantemir-Stone C.Z. Yan P. Nuovo G. et al 2013. Epigenetic regulation of miR-17-92 contributes to the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 187 (4): 397-405. 10.1164/rccm.201205-0888OC. 23306545.
19. Davies E.R. Haitchi H.M. Thatcher T.H. Sime P.J. Kottmann R.M. Ganesan A. et al 2012. Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 46 (5): 687-694. 10.1165/rcmb.2011-0040OC. 22246864.
20. Eilebrecht S. Schwartz C. Rohr O. 2013. Non-coding RNAs: novel players in chromatin-regulation during viral latency. Curr. Opin. Virol. 3 (4): 387-393. 10.1016/j.coviro.2013.04.001. 23660570.
21. Fabbri M. Garzon R. Cimmino A. Liu Z. Zanesi N. Callegari E. et al 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104 (40): 15805-15810. 10.1073/pnas.0707628104. 17890317.
22. Fang Y. Yu X. Liu Y. Kriegel A.J. Heng Y. Xu X. et al 2013. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-alpha activation. Am. J. Physiol. Renal Physiol. 304 (10): F1274-F1282. 10.1152/ajprenal.00287.2012. 23467423.
23. Fingerlin T.E. Murphy E. Zhang W. Peljto A.L. Brown K.K. Steele M.P. et al 2013. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45 (6): 613-620. 10.1038/ng.2609. 23583980.
24. Goldberg A.D. Allis C.D. Bernstein E. 2007. Epigenetics: a landscape takes shape. Cell, 128 (4): 635-638. 10.1016/j.cell.2007.02.006. 17320500.
25. Guo W. Shan B. Klingsberg R.C. Qin X. Lasky J.A. 2009. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 297 (5): L864-L870. 10.1152/ajplung.00128.2009. 19700647.
26. Heard E. Martienssen R.A. 2014. Transgenerational epigenetic inheritance: myths and mechanisms. Cell, 157 (1): 95-109. 10.1016/j.cell.2014.02.045. 24679529.
27. Helin K. Dhanak D. 2013. Chromatin proteins and modifications as drug targets. Nature, 502 (7472): 480-488. 10.1038/nature12751. 24153301.
28. Herazo-Maya J.D. Noth I. Duncan S.R. Kim S. Ma S.F. Tseng G.C. et al 2013. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci. Transl. Med. 5 (205): 205ra136. 10.1126/scitranslmed.3005964. 24089408.
29. Hu B. Gharaee-Kermani M. Wu Z. Phan S.H. 2010. Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am. J. Pathol. 177 (1): 21-28. 10.2353/ajpath.2010.090999. 20489138.
30. Hu B. Gharaee-Kermani M. Wu Z. Phan S.H. 2011. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am. J. Pathol. 178 (4): 1500-1508. 10.1016/j.ajpath.2011.01.002. 21435439.
31. Huang B. Zhang R. 2014. Regulatory non-coding RNAs: revolutionizing the RNA world. Mol. Biol. Rep. 41: 3915-3923. 10.1007/s11033-014-3259-6. 24549720.
32. Huang S.K. Fisher A.S. Scruggs A.M. White E.S. Hogaboam C.M. Richardson B.C. Peters-Golden M. 2010. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am. J. Pathol. 177 (5): 2245-2255. 10.2353/ajpath.2010.100446. 20889571.
33. Huang S.K. Scruggs A.M. Donaghy J. McEachin R.C. Fisher A.S. Richardson B.C. Peters-Golden M. 2012. Prostaglandin E(2) increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J. 26 (9): 3703-3714. 10.1096/fj.11-203323. 22645246.
34. Huang S.K. Scruggs A.M. Donaghy J. Horowitz J.C. Zaslona Z. Przybranowski S. et al 2013. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. Cell Death Dis. 4: e621. 10.1038/cddis.2013.146. 23640463.
35. Ito K. Ito M. Elliott W.M. Cosio B. Caramori G. Kon O.M. et al 2005. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352 (19): 1967-1976. 10.1056/NEJMoa041892. 15888697.
36. Izzotti A. Calin G.A. Steele V.E. Croce C.M. De Flora S. 2009. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 23 (9): 3243-3250. 10.1096/fj.09-135251. 19465468.
37. Karapetyan A.R. Buiting C. Kuiper R.A. Coolen M.W. 2013. Regulatory Roles for Long ncRNA and mRNA. Cancers (Basel), 5 (2): 462-490. 10.3390/cancers5020462. 24216986.
38. Kass D.J. Kaminski N. 2011. Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes. Clin. Transl. Sci. 4 (5): 372-379. 10.1111/j.1752-8062.2011.00287.x. 22029812.
39. Kim D.H. Nelson H.H. Wiencke J.K. Zheng S. Christiani D.C. Wain J.C. et al 2001. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 61 (8): 3419-3424. 11309302.
40. Kim H. Kwon Y.M. Kim J.S. Lee H. Park J.H. Shim Y.M. et al 2004. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J. Clin. Oncol. 22 (12): 2363-2370. 10.1200/JCO.2004.10.077. 15197197.
41. Kimmins S. Sassone-Corsi P. 2005. Chromatin remodelling and epigenetic features of germ cells. Nature, 434 (7033): 583-589. 10.1038/nature03368. 15800613.
42. Klose R.J. Zhang Y. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8 (4): 307-318. 10.1038/nrm2143. 17342184.
43. Konishi K. Gibson K.F. Lindell K.O. Richards T.J. Zhang Y. Dhir R. et al 2009. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 180 (2): 167-175. 10.1164/rccm.200810-1596OC. 19363140.
44. Kotsianidis I. Nakou E. Bouchliou I. Tzouvelekis A. Spanoudakis E. Steiropoulos P. et al 2009. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179 (12): 1121-1130. 10.1164/rccm.200812-1936OC. 19342412.
45. Kumar M. Ahmad T. Sharma A. Mabalirajan U. Kulshreshtha A. Agrawal A. Ghosh B. 2011. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol. 128 (5): 1077-1085 e1071-1010. 10.1016/j.jaci.2011.04.034. 21616524.
46. Lee J.S. Collard H.R. Anstrom K.J. Martinez F.J. Noth I. Roberts R.S. Yow E. et al.; IPFnet Investigators 2013. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir. Med. 1 (5): 369-376. 10.1016/S2213-2600(13)70105-X. 24429201.
47. Leidinger P. Keller A. Borries A. Huwer H. Rohling M. Huebers J. et al 2011. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer, 74 (1): 41-47. 10.1016/j.lungcan.2011.02.003. 21388703.
48. Leng S. Do K. Yingling C.M. Picchi M.A. Wolf H.J. Kennedy T.C. et al 2012. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin. Cancer Res. 18 (12): 3387-3395. 10.1158/1078-0432.CCR-11-3049. 22510351.
49. Lewis A. Riddoch-Contreras J. Natanek S.A. Donaldson A. Man W.D. Moxham J. et al 2012. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax, 67 (1): 26-34. 10.1136/thoraxjnl-2011-200309. 21998125.
50. Liloglou T. Bediaga N.G. Brown B.R. Field J.K. Davies M.P. 2014. Epigenetic biomarkers in lung cancer. Cancer Lett. 342 (2): 200-212. 10.1016/j.canlet.2012.04.018. 22546286.
51. Liu F. Killian J.K. Yang M. Walker R.L. Hong J.A. Zhang M. et al. 2010 a. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene, 29 (25): 3650-3664. 10.1038/onc.2010.129. 20440268.
52. Liu G. Friggeri A. Yang Y. Milosevic J. Ding Q. Thannickal V.J. et al. 2010 b. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207 (8): 1589-1597. 10.1084/jem.20100035. 20643828.
53. Liu Y. Li H. Xiao T. Lu Q. 2013. Epigenetics in immune-mediated pulmonary diseases. Clin. Rev. Allergy Immunol. 45 (3): 314-330. 10.1007/s12016-013-8398-3. 24242359.
54. Lu T.X. Hartner J. Lim E.J. Fabry V. Mingler M.K. Cole E.T. et al 2011. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 187 (6): 3362-3373. 10.4049/jimmunol.1101235. 21849676.
55. Maass P.G. Luft F.C. Bahring S. 2014. Long non-coding RNA in health and disease. J. Mol. Med. (Berl.), 92: 337-346. 10.1007/s00109-014-1131-8. 24531795.
56. Magnusdottir E. Gillich A. Grabole N. Surani M.A. 2012. Combinatorial control of cell fate and reprogramming in the mammalian germline. Curr. Opin. Genet. Dev. 22 (5): 466-474. 10.1016/j.gde.2012.06.002. 22795169.
57. Mann D.A. 2014. Epigenetics in liver disease. Hepatology, 60 (4): 1418-1425. 10.1002/hep.27131. 24633972.
58. Mann J. Oakley F. Akiboye F. Elsharkawy A. Thorne A.W. Mann D.A. 2007. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 14 (2): 275-285. 10.1038/sj.cdd.4401979. 16763620.
59. Mann J. Chu D.C. Maxwell A. Oakley F. Zhu N.L. Tsukamoto H. Mann D.A. 2010. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology, 138 (2): 705-714,. 714 e701-704. 10.1053/j.gastro.2009.10.002. 19843474.
60. Marumo T. Hishikawa K. Yoshikawa M. Hirahashi J. Kawachi S. Fujita T. 2010. Histone deacetylase modulates the proinflammatory and-fibrotic changes in tubulointerstitial injury. Am. J. Physiol. Renal Physiol. 298 (1): F133-F141. 10.1152/ajprenal.00400.2009. 19906951.
61. Mercer T.R. Dinger M.E. Mattick J.S. 2009. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10 (3): 155-159. 10.1038/nrg2521. 19188922.
62. Milosevic J. Pandit K. Magister M. Rabinovich E. Ellwanger D.C. Yu G. Vuga L.J. et al 2012. Profibrotic role of miR-154 in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 47 (6): 879-887. 10.1165/rcmb.2011-0377OC. 23043088.
63. Minagawa S. Araya J. Numata T. Nojiri S. Hara H. Yumino Y. et al 2011. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-beta-induced senescence of human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300 (3): L391-L401. 10.1152/ajplung.00097.2010. 21224216.
64. Mukasa R. Balasubramani A. Lee Y.K. Whitley S.K. Weaver B.T. Shibata Y. et al 2010. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity, 32 (5): 616-627. 10.1016/j.immuni.2010.04.016. 20471290.
65. Murphy S.K. Yang H. Moylan C.A. Pang H. Dellinger A. Abdelmalek M.F. et al 2013. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology, 145 (5): 1076-1087. 10.1053/j.gastro.2013.07.047. 23916847.
66. Nana-Sinkam S.P. Hunter M.G. Nuovo G.J. Schmittgen T.D. Gelinas R. Galas D. Marsh C.B. 2009. Integrating the MicroRNome into the study of lung disease. Am. J. Respir. Crit. Care Med. 179 (1): 4-10. 10.1164/rccm.200807-1042PP. 18787215.
67. National Lung Screening Trial Research Team; Aberle D.R. Adams A.M. Berg C.D. Black W.C. Clapp J.D. Fagerstrom R.M. et al 2011. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365 (5): 395-409. 10.1056/NEJMoa1102873. 21714641.
68. Oak S.R. Murray L. Herath A. Sleeman M. Anderson I. Joshi A.D. et al 2011. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One, 6 (6): e21253. 10.1371/journal.pone.0021253. 21712985.
69. O'Dwyer D.N. Armstrong M.E. Trujillo G. Cooke G. Keane M.P. Fallon P.G. et al 2013. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188 (12): 1442-1450. 10.1164/rccm.201304-0760OC. 24070541.
70. Ostrow K.L. Hoque M.O. Loyo M. Brait M. Greenberg A. Siegfried J.M. et al 2010. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin. Cancer Res. 16 (13): 3463-3472. 10.1158/1078-0432.CCR-09-3304. 20592015.
71. Pandit K.V. Corcoran D. Yousef H. Yarlagadda M. Tzouvelekis A. Gibson K.F. et al 2010. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182 (2): 220-229. 10.1164/rccm.200911-1698OC. 20395557.
72. Parker M.W. Rossi D. Peterson M. Smith K. Sikstrom K. White E.S. et al 2014. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124 (4): 1622-1635. 10.1172/JCI71386. 24590289.
73. Patel V. Noureddine L. 2012. MicroRNAs and fibrosis. Curr. Opin. Nephrol. Hypertens. 21 (4): 410-416. 10.1097/MNH.0b013e328354e559. 22622653.
74. Peljto A.L. Zhang Y. Fingerlin T.E. Ma S.F. Garcia J.G. Richards T.J. et al 2013. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA, 309 (21): 2232-2239. 10.1001/jama.2013.5827. 23695349.
75. Perdomo C. Spira A. Schembri F. 2011. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat. Res. 717 (1-2): 32-37. 10.1016/j.mrfmmm.2011.04.005. 21549133.
76. Perdomo C. Campbell J.D. Gerrein J. Tellez C.S. Garrison C.B. Walser T.C. et al 2013. MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 110 (47): 18946-18951. 10.1073/pnas.1220319110. 24158479.
77. Qiu W. Baccarelli A. Carey V.J. Boutaoui N. Bacherman H. Klanderman B. et al 2012. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am. J. Respir. Crit. Care Med. 185 (4): 373-381. 10.1164/rccm.201108-1382OC. 22161163.
78. Rabinovich E.I. Kapetanaki M.G. Steinfeld I. Gibson K.F. Pandit K.V. Yu G. et al. 2012 a. Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One 7 (4): e33770. 10.1371/journal.pone.0033770. 22506007.
79. Rabinovich E.I. Selman M. Kaminski N. 2012 b. Epigenomics of idiopathic pulmonary fibrosis: evaluating the first steps. Am. J. Respir. Crit. Care Med. 186 (6): 473-475. 10.1164/rccm.201208-1350ED. 22984022.
80. Raghu G. 2011. Idiopathic pulmonary fibrosis: increased survival with 'gastroesophageal reflux therapy': fact or fallacy? Am. J. Respir. Crit. Care Med. 184 (12): 1330-1332. 10.1164/rccm.201110-1842ED. 22174112.
81. Raghu G. Meyer K.C. 2012. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy? Eur. Respir. J. 39 (2): 242-245. 10.1183/09031936.00211311. 22298612.
82. Raghunath A. Hungin A.P. Wooff D. Childs S. 2003. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ, 326 (7392): 737. 10.1136/bmj.326.7392.737. 12676842.
83. Robinson C.M. Watson C.J. Baugh J.A. 2012. Epigenetics within the matrix: a neo-regulator of fibrotic disease. Epigenetics, 7 (9): 987-993. 10.4161/epi.21567. 22894907.
84. Roderburg C. Urban G.W. Bettermann K. Vucur M. Zimmermann H. Schmidt S. et al 2011. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology, 53 (1): 209-218. 10.1002/hep.23922. 20890893.
85. Rosas I.O. Yang I.V. 2013. The promise of epigenetic therapies in treatment of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 187 (4): 336-338. 10.1164/rccm.201212-2272ED. 23418324.
86. Rossetto D. Avvakumov N. Cote J. 2012. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics, 7 (10): 1098-108. 10.4161/epi.21975. 22948226.
87. Sanders Y.Y. Kumbla P. Hagood J.S. 2007. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 36 (2): 226-235. 10.1165/rcmb.2006-0178OC. 16960126.
88. Sanders Y.Y. Pardo A. Selman M. Nuovo G.J. Tollefsbol T.O. Siegal G.P. Hagood J.S. 2008. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 39 (5): 610-618. 10.1165/rcmb.2007-0322OC. 18556592.
89. Sanders Y.Y. Tollefsbol T.O. Varisco B.M. Hagood J.S. 2011. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 45 (1): 16-23. 10.1165/rcmb.2010-0154OC. 20724553.
90. Sanders Y.Y. Ambalavanan N. Halloran B. Zhang X. Liu H. Crossman D.K. et al 2012. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 186 (6): 525-535. 10.1164/rccm.201201-0077OC. 22700861.
91. Schembri F. Sridhar S. Perdomo C. Gustafson A.M. Zhang X. Ergun A. et al 2009. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 106 (7): 2319-2324. 10.1073/pnas.0806383106. 19168627.
92. Schwartz D.A. 2010. Epigenetics and environmental lung disease. Proc. Am. Thorac. Soc. 7 (2): 123-125. 10.1513/pats.200908-084RM. 20427583.
93. Seibold M.A. Wise A.L. Speer M.C. Steele M.P. Brown K.K. Loyd J.E. et al 2011. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364 (16): 1503-1512. 10.1056/NEJMoa1013660. 21506741.
94. Shen-Orr S.S. Tibshirani R. Khatri P. Khatri P. Bodian D.L. Staedtler F. et al 2010. Cell type-specific gene expression differences in complex tissues. Nat. Methods, 7 (4): 287-289. 10.1038/nmeth.1439. 20208531.
95. Shi X. Sun M. Liu H. Yao Y. Song Y. 2013. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 339 (2): 159-166. 10.1016/j.canlet.2013.06.013. 23791884.
96. Suter M. Ma J. Harris A. Patterson L. Brown K.A. Shope C. et al 2011. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics, 6 (11): 1284-1294. 10.4161/epi.6.11.17819. 21937876.
97. Tampe B. Zeisberg M. 2013. Contribution of genetics and epigenetics to progression of kidney fibrosis. Nephrol. Dial. Transplant. 10.1093/ndt/gft025. 23975750.
98. Tao H. Huang C. Yang J.J. Ma T.T. Bian E.B. Zhang L. et al 2011. MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology, 290 (2-3): 327-333. 10.1016/j.tox.2011.10.011. 22056649.
99. Tao H. Shi K.H. Yang J.J. Huang C. Liu L.P. Li J. 2013. Epigenetic regulation of cardiac fibrosis. Cell Signal. 25 (9): 1932-1938. 10.1016/j.cellsig.2013.03.024. 23602934.
100. Thum T. Gross C. Fiedler J. Fischer T. Kissler S. Bussen M. et al 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456 (7224): 980-984. 10.1038/nature07511. 19043405.
101. Van Pottelberge G.R. Mestdagh P. Bracke K.R. Thas O. van Durme Y.M. Joos G.F. et al 2011. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 183 (7): 898-906. 10.1164/rccm.201002-0304OC. 21037022.
102. van Rooij E. Sutherland L.B. Thatcher J.E. DiMaio J.M. Naseem R.H. Marshall W.S. et al 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A. 105 (35): 13027-13032. 10.1073/pnas.0805038105. 18723672.
103. Villar A.V. Garcia R. Merino D. Llano M. Cobo M. Montalvo C. et al 2013. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int. J. Cardiol. 167 (6): 2875-2881. 10.1016/j.ijcard.2012.07.021. 22882958.
104. Wang J. Huang W. Xu R. Nie Y. Cao X. Meng J. et al 2012. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J. Cell. Mol. Med. 16 (9): 2150-2160. 10.1111/j.1582-4934.2012.01523.x. 22260784.
105. Wang L. Aakre J.A. Jiang R. Marks R.S. Wu Y. Chen J. et al 2010. Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J. Thorac. Oncol. 5 (6): 778-785. 10.1097/JTO.0b013e3181d6e0b3. 20421821.
106. Wang Z. Chen C. Finger S.N. Kwajah S. Jung M. Schwarz H. et al 2009. Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis? Eur. Respir. J. 34 (1): 145-155. 10.1183/09031936.00084808. 19224893.
107. Wu C.J. Yang C.Y. Chen Y.H. Chen C.M. Chen L.C. Kuo M.L. 2013. The DNA methylation inhibitor 5-azacytidine increases regulatory T cells and alleviates airway inflammation in ovalbumin-sensitized mice. Int. Arch. Allergy Immunol. 160 (4): 356-364. 10.1159/000343030. 23183158.
108. Xiao J. Meng X.M. Huang X.R. Chung A.C. Feng Y.L. Hui D.S. et al 2012. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 20 (6): 1251-1260. 10.1038/mt.2012.36. 22395530.
109. Yang I.V. 2012. Epigenomics of idiopathic pulmonary fibrosis. Epigenomics, 4 (2): 195-203. 10.2217/epi.12.10. 22449190.
110. Yang I.V. Pedersen B.S. Rabinovich E. Hennessy C.E. Davidson E.J. Murphy E. Guardela B.J. Tedrow J.R. Zhang Y. Singh M.K. Correll M. Schwarz M.I. Geraci M. Sciurba F.C. Quackenbush J. Spira A. Kaminski N. Schwartz D.A. 2014. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 190 (11): 1263-1272. 10.1164/rccm.201408-1452OC.
111. Yang I.V. Schwartz D.A. 2011. Epigenetic control of gene expression in the lung. Am. J. Respir. Crit. Care Med. 183 (10): 1295-1301. 10.1164/rccm.201010-1579PP. 21596832.
112. Yang I.V. Schwartz D.A. 2012. Epigenetic mechanisms and the development of asthma. J. Allergy Clin. Immunol. 130 (6): 1243-1255. 10.1016/j.jaci.2012.07.052. 23026498.
113. Yang J.J. Tao H. Huang C. Shi K.H. Ma T.T. Bian E.B. et al 2013. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis. Cell Signal. 25 (5): 1202-1211. 10.1016/j.cellsig.2013.01.005. 23333245.
114. Yang S.R. Chida A.S. Bauter M.R. Shafiq N. Seweryniak K. Maggirwar S.B. et al 2006. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (1): L46-L57. 10.1152/ajplung.00241.2005. 16473865.
115. Zhang H. Chen Z. Wang X. Huang Z. He Z. Chen Y. 2013 a. Long non-coding RNA: a new player in cancer. J. Hematol. Oncol. 6: 37. 10.1186/1756-8722-6-37. 23725405.
116. Zhang X. Liu H. Hock T. Thannickal V.J. Sanders Y.Y. 2013 b. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. Int. J. Mol. Sci. 14 (10): 19605-19617. 10.3390/ijms141019605. 24084714.
117. Zhang Y. 2003. Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev. 17 (22): 2733-2740. 10.1101/gad.1156403. 14630937.
118. Zhang Y. Kanter E.M. Yamada K.A. 2010. Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovasc. Pathol. 19 (6): e233-e240. 10.1016/j.carpath.2009.12.002. 20093048.
119. Zhang Y. Huang X.R. Wei L.H. Chung A.C. Yu C.M. Lan H.Y. 2014. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling. Mol. Ther. 22 (5): 974-985. 10.1038/mt.2014.25. 24569834.